On June 17, 2020, Huang Lili, director of the Investment Promotion Department of the Management Committee of Taicang biomedical industrial park, and Li Zhiping, general manager of Taicang Xingyao Port Industrial Development Co., Ltd., visited the headquarters of Shanghai Dowell group. The leaders of the group president's office warmly received the guests.
The two guests introduced various preferential policies for investment attraction of Taicang Xingyao port. As a major project in Jiangsu Province, Xingyao port is committed to becoming a strategic highland of biomedicine in the Yangtze River Delta. The park is deeply interested in the world's leading cerebrovascular interventional medical device project invested and introduced by the group, saying that the project has large scale, strong driving force and good prospects, It can provide favorable policy support for its settlement. At the same time, the project will also help Taicang build a comprehensive industrial cluster base of international medical devices and biopharmaceuticals.